東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Cell and Organoid Models to Develop New Antivirals and Diagnostic Methods for Emerging Viruses.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Cell and Organoid Models to Develop New Antivirals and Diagnostic Methods for Emerging Viruses./
Author:	Pettke, Aleksandra.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
Description:	53 p.
Notes:	Source: Dissertations Abstracts International, Volume: 82-11, Section: B.
Contained By:	Dissertations Abstracts International82-11B.
Subject:	Physiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28518293
ISBN:	9798728224532

Cell and Organoid Models to Develop New Antivirals and Diagnostic Methods for Emerging Viruses.
Pettke, Aleksandra.

Cell and Organoid Models to Develop New Antivirals and Diagnostic Methods for Emerging Viruses. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 53 p.

Source: Dissertations Abstracts International, Volume: 82-11, Section: B.

Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2021.

This item must not be sold to any third party vendors.

The ongoing global pandemic of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) is only the latest reminder of the urgent need for new antiviral strategies and diagnostic tools to improve preparedness for emergence of new pathogenic RNA-viruses. A key obstacle for the development of antivirals and diagnostic tools has been the lack of good models to study RNA viruses. This thesis focused on cellular and organoid models for virus infection to facilitate the development of host-targeting antivirals and new diagnostic tools against emerging viruses.In Paper I, two close analogues from an in-house library of 425 host-targeting compounds were found to have antiviral activity against a pathogenic RNA virus Hazara virus (HAZV). These two hit compounds were discovered using a cell- and image-based phenotypic antiviral screening assay. Subsequently, the two compounds were confirmed to have a broad-spectrum antiviral activity against several pathogenic RNA viruses including SARS-CoV-2, Ebola and Crimean-Congo hemorrhagic fever virus. After showing the independence of the compound's antiviral effect of their originally designed target, human 8-oxoguanine glycosylase 1, thermal protein profiling was used to study the compound target. Applying this technique, the compound was revealed to disturb proteostasis pathways and interactions between cellular heat shock protein 70 complex and viral proteins.In Paper II, a second antiviral screening of in-house compounds was performed using the previously established image-based phenotypic antiviral screening assay with Zika virus (ZIKV) infected cells. The broad-spectrum activity of the compounds was confirmed by revealing the same compounds to be active against both HAZV and ZIKV. Next, the therapeutic window and antiviral activity of the top-hit compounds was demonstrated in several cellular models of ZIKV infection. Additionally, the novel antiviral compounds showed an antiviral effect and reversed ZIKV induced neurotoxicity in iPS cell derived human brain organoids. Furthermore, mechanism-of-action studies revealed the compound to impair the formation of new virus particles in the late lifecycle steps.In Paper III, the development of a new diagnostic tool for ZIKV is described using in vitro infected U87 cells and PBMCs. In the method presented, ZIKV cDNA was hybridized using padlock probes and amplified by two rounds of Circle-to-Circle Amplification. Detection was performed using a microfluidic affinity chromatography enrichment platform. Benchmarking of the newly developed method against RT-qPCR, the gold standard diagnostic method for ZIKV detection, confirmed a good correlation between both methods.Altogether, this thesis demonstrates how cell culture tools with varying complexity, unique advantages and challenges can be used to augment the development of novel antiviral drugs and diagnostic methods.

ISBN: 9798728224532Subjects--Topical Terms:

518431
Physiology.
Subjects--Index Terms:

Congenital diseases

Cell and Organoid Models to Develop New Antivirals and Diagnostic Methods for Emerging Viruses.
LDR:04296nmm a2200421 4500 001 2347075
005 20220711065242.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798728224532
035 $a (MiAaPQ)AAI28518293
035 $a (MiAaPQ)Karolinska_1061647567
035 $a AAI28518293
040 $a MiAaPQ $c MiAaPQ
100 1 $a Pettke, Aleksandra. $3 3686287
245 1 0 $a Cell and Organoid Models to Develop New Antivirals and Diagnostic Methods for Emerging Viruses.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 53 p.
500 $a Source: Dissertations Abstracts International, Volume: 82-11, Section: B.
500 $a Includes supplementary digital materials.
500 $a Advisor: Helleday, Thomas;Mirazimi, Ali;Puumalainen, Marjo-Riitta;Rosenquist, Asa.
502 $a Thesis (Ph.D.)--Karolinska Institutet (Sweden), 2021.
506 $a This item must not be sold to any third party vendors.
520 $a The ongoing global pandemic of severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) is only the latest reminder of the urgent need for new antiviral strategies and diagnostic tools to improve preparedness for emergence of new pathogenic RNA-viruses. A key obstacle for the development of antivirals and diagnostic tools has been the lack of good models to study RNA viruses. This thesis focused on cellular and organoid models for virus infection to facilitate the development of host-targeting antivirals and new diagnostic tools against emerging viruses.In Paper I, two close analogues from an in-house library of 425 host-targeting compounds were found to have antiviral activity against a pathogenic RNA virus Hazara virus (HAZV). These two hit compounds were discovered using a cell- and image-based phenotypic antiviral screening assay. Subsequently, the two compounds were confirmed to have a broad-spectrum antiviral activity against several pathogenic RNA viruses including SARS-CoV-2, Ebola and Crimean-Congo hemorrhagic fever virus. After showing the independence of the compound's antiviral effect of their originally designed target, human 8-oxoguanine glycosylase 1, thermal protein profiling was used to study the compound target. Applying this technique, the compound was revealed to disturb proteostasis pathways and interactions between cellular heat shock protein 70 complex and viral proteins.In Paper II, a second antiviral screening of in-house compounds was performed using the previously established image-based phenotypic antiviral screening assay with Zika virus (ZIKV) infected cells. The broad-spectrum activity of the compounds was confirmed by revealing the same compounds to be active against both HAZV and ZIKV. Next, the therapeutic window and antiviral activity of the top-hit compounds was demonstrated in several cellular models of ZIKV infection. Additionally, the novel antiviral compounds showed an antiviral effect and reversed ZIKV induced neurotoxicity in iPS cell derived human brain organoids. Furthermore, mechanism-of-action studies revealed the compound to impair the formation of new virus particles in the late lifecycle steps.In Paper III, the development of a new diagnostic tool for ZIKV is described using in vitro infected U87 cells and PBMCs. In the method presented, ZIKV cDNA was hybridized using padlock probes and amplified by two rounds of Circle-to-Circle Amplification. Detection was performed using a microfluidic affinity chromatography enrichment platform. Benchmarking of the newly developed method against RT-qPCR, the gold standard diagnostic method for ZIKV detection, confirmed a good correlation between both methods.Altogether, this thesis demonstrates how cell culture tools with varying complexity, unique advantages and challenges can be used to augment the development of novel antiviral drugs and diagnostic methods.
590 $a School code: 0658.
650 4 $a Physiology. $3 518431
650 4 $a Epidemiology. $3 568544
650 4 $a Pathology. $3 643180
650 4 $a Virology. $3 642304
653 $a Congenital diseases
653 $a Zika virus
653 $a Brain research
653 $a Ebola virus
653 $a Coronaviruses
653 $a Disease transmission
690 $a 0720
690 $a 0766
690 $a 0719
690 $a 0571
710 2 $a Karolinska Institutet (Sweden). $3 3557748
773 0 $t Dissertations Abstracts International $g 82-11B.
790 $a 0658
791 $a Ph.D.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28518293